Sandy Spring Bank Seres Therapeutics, Inc. Transaction History
Sandy Spring Bank
- $2.33 Billion
- Q1 2025
A detailed history of Sandy Spring Bank transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Sandy Spring Bank holds 345 shares of MCRB stock, worth $5,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345
Previous 345
-0.0%
Holding current value
$5,326
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MCRB
# of Institutions
9Shares Held
1.98MCall Options Held
10KPut Options Held
0-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Miller Financial Services LLC Marshall, MI15KShares$231,6000.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V813.7KShares$211,4040.0% of portfolio
-
Jpmorgan Chase & CO New York, NY1.3KShares$20,1330.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ160Shares$2,4700.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...